Proposed guidelines for protocol studies. I. Introduction. II. Plasma cell myeloma. 3. Chronic lymphocytic leukemia. IV. Chronic granulocytic leukemia.
D000970:Antineoplastic Agents / Q000008:administration & dosage; D002986:Clinical Trials as Topic; D006801:Humans; D007154:Immune System Diseases / Q000175:diagnosis; D007938:Leukemia / Q000175:diagnosis / Q000188:drug therapy*; D007945:Leukemia, Lymphoid / Q000145:classification / Q000175:diagnosis; D007951:Leukemia, Myeloid / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy; D009101:Multiple Myeloma / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D010950:Plasma Cells / Q000276:immunology
D000970:Antineoplastic Agents